Year |
Citation |
Score |
2022 |
Moore BD, Levites Y, Xu G, Hampton H, Adamo MF, Croft CL, Futch HS, Moran C, Fromholt S, Janus C, Prokop S, Dickson D, Lewis J, Giasson BI, Golde TE, et al. Soluble brain homogenates from diverse human and mouse sources preferentially seed diffuse Aβ plaque pathology when injected into newborn mouse hosts. Free Neuropathology. 3. PMID 35494163 DOI: 10.17879/freeneuropathology-2022-3766 |
0.328 |
|
2022 |
Xu G, Ulm BS, Howard J, Fromholt SE, Lu Q, Lee BB, Walker A, Borchelt DR, Lewis J. TAPPing into the potential of inducible tau/APP transgenic mice. Neuropathology and Applied Neurobiology. PMID 35067965 DOI: 10.1111/nan.12791 |
0.348 |
|
2020 |
Xu G, Fromholt SE, Chakrabarty P, Zhu F, Liu X, Pace MC, Koh J, Golde TE, Levites Y, Lewis J, Borchelt DR. Diversity in Aβ deposit morphology and secondary proteome insolubility across models of Alzheimer-type amyloidosis. Acta Neuropathologica Communications. 8: 43. PMID 32252825 DOI: 10.1186/S40478-020-00911-Y |
0.405 |
|
2020 |
Koller EJ, Gonzalez De La Cruz E, Weinrich M, Williams T, Cruz PE, Ryu D, Golde TE, Sullivan PM, Lewis J, Borchelt DR, Chakrabarty P. Intracerebral Expression of AAV-APOE4 Is Not Sufficient to Alter Tau Burden in Two Distinct Models of Tauopathy. Molecular Neurobiology. PMID 31903524 DOI: 10.1007/S12035-019-01859-4 |
0.486 |
|
2018 |
Bardai FH, Ordonez DG, Bailey RM, Hamm M, Lewis J, Feany MB. Lrrk promotes tau neurotoxicity through dysregulation of actin and mitochondrial dynamics. Plos Biology. 16: e2006265. PMID 30571694 DOI: 10.1371/Journal.Pbio.2006265 |
0.612 |
|
2018 |
Moloney C, Rayaprolu S, Howard J, Fromholt S, Brown H, Collins M, Cabrera M, Duffy C, Siemienski Z, Miller D, Borchelt DR, Lewis J. Analysis of spinal and muscle pathology in transgenic mice overexpressing wild-type and ALS-linked mutant MATR3. Acta Neuropathologica Communications. 6: 137. PMID 30563574 DOI: 10.1186/S40478-018-0631-0 |
0.803 |
|
2018 |
Hamm M, Ladd TB, Levites Y, Golde TE, Giasson BI, Lewis J. Designing antibodies against LRRK2-targeted tau epitopes. Plos One. 13: e0204367. PMID 30261006 DOI: 10.1371/Journal.Pone.0204367 |
0.385 |
|
2018 |
Pace MC, Xu G, Fromholt S, Howard J, Crosby K, Giasson BI, Lewis J, Borchelt DR. Changes in proteome solubility indicate widespread proteostatic disruption in mouse models of neurodegenerative disease. Acta Neuropathologica. PMID 30140941 DOI: 10.1007/S00401-018-1895-Y |
0.442 |
|
2018 |
Rayaprolu S, Seven YB, Howard J, Duffy C, Altshuler M, Moloney C, Giasson BI, Lewis J. Partial loss of ATP13A2 causes selective gliosis independent of robust lipofuscinosis. Molecular and Cellular Neurosciences. PMID 29859891 DOI: 10.1016/J.Mcn.2018.05.009 |
0.793 |
|
2018 |
Pace MC, Xu G, Fromholt S, Howard J, Giasson BI, Lewis J, Borchelt DR. Differential induction of mutant SOD1 misfolding and aggregation by tau and α-synuclein pathology. Molecular Neurodegeneration. 13: 23. PMID 29776378 DOI: 10.1186/S13024-018-0253-9 |
0.361 |
|
2018 |
Iradi MCG, Triplett JC, Thomas JD, Davila R, Crown AM, Brown H, Lewis J, Swanson MS, Xu G, Rodriguez-Lebron E, Borchelt DR. Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy. Scientific Reports. 8: 4049. PMID 29511296 DOI: 10.1038/S41598-018-21371-4 |
0.343 |
|
2017 |
Moloney C, Rayaprolu S, Howard J, Fromholt S, Brown H, Collins M, Cabrera M, Duffy C, Siemienski Z, Miller D, Swanson MS, Notterpek L, Borchelt DR, Lewis J. Retraction Note: Transgenic mice overexpressing the ALS-linked protein Matrin 3 develop a profound muscle phenotype. Acta Neuropathologica Communications. 5: 97. PMID 29237481 DOI: 10.1186/S40478-017-0502-0 |
0.797 |
|
2017 |
Khare S, Nick JA, Zhang Y, Galeano K, Butler B, Khoshbouei H, Rayaprolu S, Hathorn T, Ranum LPW, Smithson L, Golde TE, Paucar M, Morse R, Raff M, Simon J, ... ... Lewis J, et al. A KCNC3 mutation causes a neurodevelopmental, non-progressive SCA13 subtype associated with dominant negative effects and aberrant EGFR trafficking. Plos One. 12: e0173565. PMID 28467418 DOI: 10.1371/Journal.Pone.0173565 |
0.706 |
|
2016 |
Moloney C, Rayaprolu S, Howard J, Fromholt S, Brown H, Collins M, Cabrera M, Duffy C, Siemienski Z, Miller D, Swanson MS, Notterpek L, Borchelt DR, Lewis J. Transgenic mice overexpressing the ALS-linked protein Matrin 3 develop a profound muscle phenotype. Acta Neuropathologica Communications. 4: 122. PMID 27863507 DOI: 10.1186/S40478-016-0393-5 |
0.801 |
|
2016 |
Fromholt S, Reitano C, Brown H, Lewis J, Borchelt DR. Generation of a new transgenic mouse model for assessment of tau gene silencing therapies. Alzheimer's Research & Therapy. 8: 36. PMID 27593210 DOI: 10.1186/S13195-016-0202-1 |
0.386 |
|
2016 |
Rayaprolu S, D'Alton S, Crosby K, Moloney C, Howard J, Duffy C, Cabrera M, Siemienski Z, Hernandez AR, Gallego-Iradi C, Borchelt DR, Lewis J. Heterogeneity of Matrin 3 in the developing and aging murine central nervous system. The Journal of Comparative Neurology. PMID 26878116 DOI: 10.1002/Cne.23986 |
0.772 |
|
2015 |
Lewis J, Dickson DW. Propagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathologica. PMID 26576562 DOI: 10.1007/S00401-015-1507-Z |
0.531 |
|
2015 |
Gallego-Iradi MC, Clare AM, Brown HH, Janus C, Lewis J, Borchelt DR. Subcellular Localization of Matrin 3 Containing Mutations Associated with ALS and Distal Myopathy. Plos One. 10: e0142144. PMID 26528920 DOI: 10.1371/Journal.Pone.0142144 |
0.348 |
|
2015 |
Li A, Ceballos-Diaz C, DiNunno N, Levites Y, Cruz PE, Lewis J, Golde TE, Chakrabarty P. IFN-γ promotes τ phosphorylation without affecting mature tangles. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 26156074 DOI: 10.1096/Fj.15-275834 |
0.323 |
|
2015 |
Hamm M, Bailey R, Shaw G, Yen SH, Lewis J, Giasson BI. Physiologically relevant factors influence tau phosphorylation by leucine-rich repeat kinase 2. Journal of Neuroscience Research. PMID 26123245 DOI: 10.1002/Jnr.23614 |
0.579 |
|
2015 |
D'Alton S, Altshuler M, Lewis J. Studies of alternative isoforms provide insight into TDP-43 autoregulation and pathogenesis. Rna (New York, N.Y.). 21: 1419-32. PMID 26089325 DOI: 10.1261/Rna.047647.114 |
0.725 |
|
2015 |
Chakrabarty P, Hudson Iii VJ, Sacino AN, Brooks MM, D'Alton S, Lewis J, Golde TE, Giasson BI. Inefficient induction and spread of seeded tau pathology in P301L mouse model of tauopathy suggests inherent physiological barriers to transmission. Acta Neuropathologica. 130: 303-5. PMID 25982997 DOI: 10.1007/S00401-015-1444-X |
0.773 |
|
2014 |
D'Alton S, Lewis J. Understanding the role of progranulin in Alzheimer's disease. Nature Medicine. 20: 1099-100. PMID 25295938 DOI: 10.1038/Nm.3712 |
0.741 |
|
2014 |
D'Alton S, Lewis J. Therapeutic and diagnostic challenges for frontotemporal dementia. Frontiers in Aging Neuroscience. 6: 204. PMID 25191265 DOI: 10.3389/Fnagi.2014.00204 |
0.742 |
|
2014 |
Stoica R, De Vos KJ, Paillusson S, Mueller S, Sancho RM, Lau KF, Vizcay-Barrena G, Lin WL, Xu YF, Lewis J, Dickson DW, Petrucelli L, Mitchell JC, Shaw CE, Miller CC. ER-mitochondria associations are regulated by the VAPB-PTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43. Nature Communications. 5: 3996. PMID 24893131 DOI: 10.1038/Ncomms4996 |
0.395 |
|
2014 |
Schirer Y, Malishkevich A, Ophir Y, Lewis J, Giladi E, Gozes I. Novel marker for the onset of frontotemporal dementia: early increase in activity-dependent neuroprotective protein (ADNP) in the face of Tau mutation. Plos One. 9: e87383. PMID 24489906 DOI: 10.1371/Journal.Pone.0087383 |
0.438 |
|
2014 |
D'Alton S, Altshuler M, Cannon A, Dickson DW, Petrucelli L, Lewis J. Divergent phenotypes in mutant TDP-43 transgenic mice highlight potential confounds in TDP-43 transgenic modeling. Plos One. 9: e86513. PMID 24466128 DOI: 10.1371/Journal.Pone.0086513 |
0.825 |
|
2014 |
Frost B, Hemberg M, Lewis J, Feany MB. Tau promotes neurodegeneration through global chromatin relaxation. Nature Neuroscience. 17: 357-66. PMID 24464041 DOI: 10.1038/Nn.3639 |
0.436 |
|
2014 |
Bailey RM, Howard J, Knight J, Sahara N, Dickson DW, Lewis J. Effects of the C57BL/6 strain background on tauopathy progression in the rTg4510 mouse model. Molecular Neurodegeneration. 9: 8. PMID 24428919 DOI: 10.1186/1750-1326-9-8 |
0.687 |
|
2014 |
Sahara N, Perez PD, Lin WL, Dickson DW, Ren Y, Zeng H, Lewis J, Febo M. Age-related decline in white matter integrity in a mouse model of tauopathy: an in vivo diffusion tensor magnetic resonance imaging study. Neurobiology of Aging. 35: 1364-74. PMID 24411290 DOI: 10.1016/J.Neurobiolaging.2013.12.009 |
0.515 |
|
2014 |
Ren Y, Sahara N, Giasson B, Lewis J. Tauopathy Mouse Models Movement Disorders: Genetics and Models: Second Edition. 849-855. DOI: 10.1016/B978-0-12-405195-9.00055-X |
0.353 |
|
2013 |
Zu T, Liu Y, Bañez-Coronel M, Reid T, Pletnikova O, Lewis J, Miller TM, Harms MB, Falchook AE, Subramony SH, Ostrow LW, Rothstein JD, Troncoso JC, Ranum LP. RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proceedings of the National Academy of Sciences of the United States of America. 110: E4968-77. PMID 24248382 DOI: 10.1073/Pnas.1315438110 |
0.355 |
|
2013 |
Golde TE, Lewis J, McFarland NR. Anti-tau antibodies: hitting the target. Neuron. 80: 254-6. PMID 24139027 DOI: 10.1016/J.Neuron.2013.10.009 |
0.392 |
|
2013 |
Bailey RM, Covy JP, Melrose HL, Rousseau L, Watkinson R, Knight J, Miles S, Farrer MJ, Dickson DW, Giasson BI, Lewis J. LRRK2 phosphorylates novel tau epitopes and promotes tauopathy. Acta Neuropathologica. 126: 809-27. PMID 24113872 DOI: 10.1007/S00401-013-1188-4 |
0.644 |
|
2013 |
Maruyama M, Shimada H, Suhara T, Shinotoh H, Ji B, Maeda J, Zhang MR, Trojanowski JQ, Lee VM, Ono M, Masamoto K, Takano H, Sahara N, Iwata N, Okamura N, ... ... Lewis J, et al. Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls. Neuron. 79: 1094-108. PMID 24050400 DOI: 10.1016/J.Neuron.2013.07.037 |
0.357 |
|
2013 |
Rutherford NJ, Lewis J, Clippinger AK, Thomas MA, Adamson J, Cruz PE, Cannon A, Xu G, Golde TE, Shaw G, Borchelt DR, Giasson BI. Unbiased screen reveals ubiquilin-1 and -2 highly associated with huntingtin inclusions. Brain Research. 1524: 62-73. PMID 23774650 DOI: 10.1016/J.Brainres.2013.06.006 |
0.616 |
|
2013 |
Lincoln S, Allen M, Cox CL, Walker LP, Malphrus K, Qiu Y, Nguyen T, Rowley C, Kouri N, Crook J, Pankratz VS, Younkin S, Younkin L, Carrasquillo M, Zou F, ... ... Lewis JM, et al. LRRTM3 interacts with APP and BACE1 and has variants associating with late-onset Alzheimer's disease (LOAD). Plos One. 8: e64164. PMID 23750206 DOI: 10.1371/Journal.Pone.0064164 |
0.417 |
|
2013 |
Sacino AN, Thomas MA, Ceballos-Diaz C, Cruz PE, Rosario AM, Lewis J, Giasson BI, Golde TE. Conformational templating of α-synuclein aggregates in neuronal-glial cultures. Molecular Neurodegeneration. 8: 17. PMID 23714769 DOI: 10.1186/1750-1326-8-17 |
0.341 |
|
2013 |
Clippinger AK, D'Alton S, Lin WL, Gendron TF, Howard J, Borchelt DR, Cannon A, Carlomagno Y, Chakrabarty P, Cook C, Golde TE, Levites Y, Ranum L, Schultheis PJ, Xu G, ... ... Lewis J, et al. Robust cytoplasmic accumulation of phosphorylated TDP-43 in transgenic models of tauopathy. Acta Neuropathologica. 126: 39-50. PMID 23666556 DOI: 10.1007/S00401-013-1123-8 |
0.828 |
|
2013 |
Golde TE, Borchelt DR, Giasson BI, Lewis J. Thinking laterally about neurodegenerative proteinopathies. The Journal of Clinical Investigation. 123: 1847-55. PMID 23635781 DOI: 10.1172/Jci66029 |
0.33 |
|
2013 |
Schultheis PJ, Fleming SM, Clippinger AK, Lewis J, Tsunemi T, Giasson B, Dickson DW, Mazzulli JR, Bardgett ME, Haik KL, Ekhator O, Chava AK, Howard J, Gannon M, Hoffman E, et al. Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited α-synuclein accumulation and age-dependent sensorimotor deficits. Human Molecular Genetics. 22: 2067-82. PMID 23393156 DOI: 10.1093/Hmg/Ddt057 |
0.554 |
|
2013 |
Perez PD, Hall G, Kimura T, Ren Y, Bailey RM, Lewis J, Febo M, Sahara N. In vivo functional brain mapping in a conditional mouse model of human tauopathy (tauP301L) reveals reduced neural activity in memory formation structures. Molecular Neurodegeneration. 8: 9. PMID 23379588 DOI: 10.1186/1750-1326-8-9 |
0.642 |
|
2013 |
Sahara N, DeTure M, Ren Y, Ebrahim AS, Kang D, Knight J, Volbracht C, Pedersen JT, Dickson DW, Yen SH, Lewis J. Characteristics of TBS-extractable hyperphosphorylated tau species: aggregation intermediates in rTg4510 mouse brain. Journal of Alzheimer's Disease : Jad. 33: 249-63. PMID 22941973 DOI: 10.3233/Jad-2012-121093 |
0.517 |
|
2012 |
Gass J, Lee WC, Cook C, Finch N, Stetler C, Jansen-West K, Lewis J, Link CD, Rademakers R, Nykjær A, Petrucelli L. Progranulin regulates neuronal outgrowth independent of sortilin. Molecular Neurodegeneration. 7: 33. PMID 22781549 DOI: 10.1186/1750-1326-7-33 |
0.527 |
|
2012 |
Smith KR, Damiano J, Franceschetti S, Carpenter S, Canafoglia L, Morbin M, Rossi G, Pareyson D, Mole SE, Staropoli JF, Sims KB, Lewis J, Lin WL, Dickson DW, Dahl HH, et al. Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage. American Journal of Human Genetics. 90: 1102-7. PMID 22608501 DOI: 10.1016/J.Ajhg.2012.04.021 |
0.489 |
|
2012 |
Cannon A, Yang B, Knight J, Farnham IM, Zhang Y, Wuertzer CA, D'Alton S, Lin WL, Castanedes-Casey M, Rousseau L, Scott B, Jurasic M, Howard J, Yu X, Bailey R, ... ... Lewis J, et al. Neuronal sensitivity to TDP-43 overexpression is dependent on timing of induction. Acta Neuropathologica. 123: 807-23. PMID 22539017 DOI: 10.1007/S00401-012-0979-3 |
0.813 |
|
2012 |
Bailey R, Cannon A, Melrose H, Farrer M, Dickson D, Lewis J. P1-195: LRRK2 modulation of neuropathology in a mouse model of tauopathy Alzheimer's & Dementia. 8: P175-P175. DOI: 10.1016/J.Jalz.2012.05.473 |
0.707 |
|
2012 |
Lewis J, Cannon A, D'Alton S, Dickson DW, Petrucelli L. S5-02-02: Lessons learned from emerging mouse models of TDP-43 proteinopathy Alzheimer's & Dementia. 8: P725-P725. DOI: 10.1016/J.Jalz.2012.05.1949 |
0.76 |
|
2012 |
D'Alton S, Altshuler M, Cannon A, Dickson D, Petrucelli L, Lewis J. O4-07-06: Influence on phenotype of the postnatal developmental period in mice expressing human M337V TDP-43 Alzheimer's & Dementia. 8: P628-P629. DOI: 10.1016/J.Jalz.2012.05.1676 |
0.793 |
|
2011 |
Xu YF, Zhang YJ, Lin WL, Cao X, Stetler C, Dickson DW, Lewis J, Petrucelli L. Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice. Molecular Neurodegeneration. 6: 73. PMID 22029574 DOI: 10.1186/1750-1326-6-73 |
0.601 |
|
2011 |
Crimins JL, Rocher AB, Peters A, Shultz P, Lewis J, Luebke JI. Homeostatic responses by surviving cortical pyramidal cells in neurodegenerative tauopathy. Acta Neuropathologica. 122: 551-64. PMID 21968531 DOI: 10.1007/S00401-011-0877-0 |
0.367 |
|
2011 |
Ludvigson AE, Luebke JI, Lewis J, Peters A. Structural abnormalities in the cortex of the rTg4510 mouse model of tauopathy: a light and electron microscopy study. Brain Structure & Function. 216: 31-42. PMID 21152933 DOI: 10.1007/S00429-010-0295-4 |
0.451 |
|
2011 |
Morgan D, Munireddy S, Alamed J, DeLeon J, Diamond DM, Bickford P, Hutton M, Lewis J, McGowan E, Gordon MN. Apparent behavioral benefits of tau overexpression in P301L tau transgenic mice Advances in Alzheimer's Disease. 1: 129-138. DOI: 10.3233/978-1-60750-733-8-129 |
0.543 |
|
2011 |
D'Alton S, Altshuler M, Lewis J. P4-139: Characterisation of alternative isoforms of TDP-43 Alzheimer's & Dementia. 7: S752-S752. DOI: 10.1016/J.Jalz.2011.05.2161 |
0.703 |
|
2011 |
Abisambra J, Cannon A, O'Leary J, Brady S, Espinosa A, Jinwal U, Koren J, Blair L, Lewis J, Dickey C. O4-04-08: Neuronal tau-specific stress induction of molecular chaperones: The failure of a coping mechanism Alzheimer's & Dementia. 7: S691-S691. DOI: 10.1016/J.Jalz.2011.05.1996 |
0.673 |
|
2011 |
Cannon A, Yang B, Knight J, Farnham M, Zhang Y, Wuertzer C, D'Alton S, Howard J, Lin W, Scott B, Jurasic M, Yu X, Bailey R, Dickson D, Petrucelli L, ... Lewis J, et al. P3-006: Neurons during early development are highly vulnerable to TDP-43 dysregulation Alzheimer's & Dementia. 7: S517-S517. DOI: 10.1016/J.Jalz.2011.05.1445 |
0.765 |
|
2011 |
Bailey R, Howard J, Knight J, Dickson D, Lewis J. P3-003: Effect of strain background on pathology progression in tau mouse model Alzheimer's & Dementia. 7: S515-S516. DOI: 10.1016/J.Jalz.2011.05.1442 |
0.64 |
|
2011 |
Sahara N, Melrose H, D'alton S, Lewis J. Transgenic Animal Models of Proteinopathies Neurodegeneration: the Molecular Pathology of Dementia and Movement Disorders: Second Edition. 26-36. DOI: 10.1002/9781444341256.ch7 |
0.715 |
|
2010 |
Lewis J, Golde TE. Sorting out frontotemporal dementia? Neuron. 68: 601-3. PMID 21092851 DOI: 10.1016/J.Neuron.2010.11.014 |
0.358 |
|
2010 |
Sahara N, Lewis J. Amyloid precursor protein and tau transgenic models of Alzheimer's disease: insights from the past and directions for the future. Future Neurology. 5: 411-420. PMID 20730022 DOI: 10.2217/Fnl.10.10 |
0.444 |
|
2010 |
Xu YF, Gendron TF, Zhang YJ, Lin WL, D'Alton S, Sheng H, Casey MC, Tong J, Knight J, Yu X, Rademakers R, Boylan K, Hutton M, McGowan E, Dickson DW, ... Lewis J, et al. Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 10851-9. PMID 20702714 DOI: 10.1523/Jneurosci.1630-10.2010 |
0.83 |
|
2010 |
Ahmed Z, Sheng H, Xu YF, Lin WL, Innes AE, Gass J, Yu X, Wuertzer CA, Hou H, Chiba S, Yamanouchi K, Leissring M, Petrucelli L, Nishihara M, Hutton ML, ... ... Lewis J, et al. Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggest a role for progranulin in successful aging. The American Journal of Pathology. 177: 311-24. PMID 20522652 DOI: 10.2353/Ajpath.2010.090915 |
0.658 |
|
2010 |
Golde TE, Petrucelli L, Lewis J. Targeting Abeta and tau in Alzheimer's disease, an early interim report. Experimental Neurology. 223: 252-66. PMID 19716367 DOI: 10.1016/J.Expneurol.2009.07.035 |
0.395 |
|
2010 |
Rocher AB, Crimins JL, Amatrudo JM, Kinson MS, Todd-Brown MA, Lewis J, Luebke JI. Structural and functional changes in tau mutant mice neurons are not linked to the presence of NFTs Experimental Neurology. 223: 385-393. PMID 19665462 DOI: 10.1016/J.Expneurol.2009.07.029 |
0.423 |
|
2010 |
Ahmed Z, Sheng H, Xu YF, Lin WL, Innes AE, Gass J, Yu X, Wuertzer CA, Hou H, Chiba S, Yamanouchi K, Leissring M, Petrucelli L, Nishihara M, Hutton ML, ... ... Lewis J, et al. Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggest a role for progranulin in successful aging (American Journal of Pathology (2010), 177, (311-324)) American Journal of Pathology. 177: 2146. DOI: 10.2353/Ajpath.2010.100772 |
0.614 |
|
2010 |
Sahara N, DeTure M, Abdul-Shukkur E, Christensen S, Kang D, Knight J, Volbracht C, Petrucelli L, Yen S, Lewis J. P1-371: Characteristics of cytosolic hyperphosphorylated tau species in rTg4510 mouse brain Alzheimer's & Dementia. 6: S280-S281. DOI: 10.1016/J.Jalz.2010.05.925 |
0.346 |
|
2010 |
Xu Y, Gendron T, Zhang Y, Lin W, D'Alton S, Sheng H, Crook R, Casey MC, Tong J, Knight J, Yu X, Rademakers R, Boylan K, Hutton M, McGowan E, ... ... Lewis J, et al. P1-185: Wild-type human TDP-43 induces mitochondrial abnormalities and axonal degeneration in transgenic mice Alzheimer's & Dementia. 6: S227-S227. DOI: 10.1016/J.Jalz.2010.05.735 |
0.795 |
|
2010 |
Cannon AD, Zhang Y, Knight J, Xu Y, Dickson DW, Petrucelli L, Lewis J. P1-179: Inducible expression of wild-type TDP-43 is toxic to mouse hippocampal and cortical neurons Alzheimer's & Dementia. 6: S225-S226. DOI: 10.1016/J.Jalz.2010.05.729 |
0.471 |
|
2010 |
Gass JM, Cook C, Rademakers R, Lewis J, Petrucelli L. O1-07-02: Loss of progranulin and its impact on neuronal function Alzheimer's & Dementia. 6: S83-S83. DOI: 10.1016/J.Jalz.2010.05.250 |
0.462 |
|
2010 |
Ahmed Z, Sheng H, Xu Y, Lin W, Innes AE, Yu X, Hou H, Chiba S, Yamanouchi K, Petrucelli L, Nishihara M, Hutton ML, McGowan E, Dickson DW, Lewis J. Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggests a role for progranulin in successful aging Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.249 |
0.495 |
|
2010 |
Lewis J, Xu Y, Cannon A, Zhang Y, Lin W, Hutton M, McGowan E, Dickson DW, Petrucelli L. O1-04-04: TDP-43 mouse models: Tools toward understanding the normal and disease roles for TDP-43 Alzheimer's & Dementia. 6: S77-S77. DOI: 10.1016/J.Jalz.2010.05.228 |
0.688 |
|
2010 |
D'Alton S, Xu Y, Zhang Y, Dickson DW, Lewis J, Petrucelli L. Gene expression analysis of TDP-43 transgenic mice Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.1273 |
0.77 |
|
2009 |
Cook C, Gass J, Dunmore J, Tong J, Taylor J, Eriksen J, McGowan E, Lewis J, Johnston J, Petrucelli L. Aging is not associated with proteasome impairment in UPS reporter mice. Plos One. 4: e5888. PMID 19517018 DOI: 10.1371/Journal.Pone.0005888 |
0.406 |
|
2009 |
Dickey C, Kraft C, Jinwal U, Koren J, Johnson A, Anderson L, Lebson L, Lee D, Dickson D, de Silva R, Binder LI, Morgan D, Lewis J. Aging analysis reveals slowed tau turnover and enhanced stress response in a mouse model of tauopathy. The American Journal of Pathology. 174: 228-38. PMID 19074615 DOI: 10.2353/Ajpath.2009.080764 |
0.721 |
|
2009 |
Lewis JM, Ahmed Z, Sheng H, Xu Y, Lin W, Innes A, Hou H, Hutton ML, McGowan E, Dickson DW. O4-06-01: Neuropathological characterization of progranulin-deficient mice: Accelerated lipofuscin accumulation suggests a role for progranulin in successful aging Alzheimer's & Dementia. 5: P161-P162. DOI: 10.1016/J.Jalz.2009.05.558 |
0.415 |
|
2009 |
Cannon AD, De Ture M, Knight J, Alosilla D, Dickson DW, Sahara N, Volbracht C, Lewis J. P3-198: Induction of mutant tau expression in aged rTg4510 mice does not rapidly induce tauopathy Alzheimer's & Dementia. 5: P400-P401. DOI: 10.1016/J.Jalz.2009.04.1072 |
0.547 |
|
2009 |
Barten DM, Meredith JE, Andorfer C, Polson C, Hoque N, Fiedler T, DeCarr LB, Goldstein M, Raybon JJ, Donegan M, Corradi J, Yang L, Janus C, Hutton M, Lewis J, et al. P3-187: Microtubule stabilizing agents as tools to explore the mechanism of Tau neurotoxicity in Alzheimer's disease and other Tauopathies Alzheimer's & Dementia. 5: P398-P398. DOI: 10.1016/J.Jalz.2009.04.1061 |
0.542 |
|
2009 |
Sahara N, Kang D, Yamashita S, Kimura T, Takashima A, Lewis J. P3-182: Examining the link between synaptosomal accumulation of tau protein and cognitive dysfunction Alzheimer's & Dementia. 5: P397-P397. DOI: 10.1016/J.Jalz.2009.04.1056 |
0.32 |
|
2008 |
Morgan D, Munireddy S, Alamed J, DeLeon J, Diamond DM, Bickford P, Hutton M, Lewis J, McGowan E, Gordon MN. Apparent behavioral benefits of tau overexpression in P301L tau transgenic mice. Journal of Alzheimer's Disease : Jad. 15: 605-14. PMID 19096159 DOI: 10.3233/Jad-2008-15407 |
0.627 |
|
2008 |
Lewis J, Melrose H, Bumcrot D, Hope A, Zehr C, Lincoln S, Braithwaite A, He Z, Ogholikhan S, Hinkle K, Kent C, Toudjarska I, Charisse K, Braich R, Pandey RK, et al. In vivo silencing of alpha-synuclein using naked siRNA. Molecular Neurodegeneration. 3: 19. PMID 18976489 DOI: 10.1186/1750-1326-3-19 |
0.331 |
|
2008 |
Eriksen JL, Zehr C, Lewis J. Biologic models of neurodegenerative disorders. Handbook of Clinical Neurology. 89: 173-88. PMID 18631742 DOI: 10.1016/S0072-9752(07)01216-X |
0.381 |
|
2008 |
Vega IE, Traverso EE, Ferrer-Acosta Y, Matos E, Colon M, Gonzalez J, Dickson D, Hutton M, Lewis J, Yen SH. A novel calcium-binding protein is associated with tau proteins in tauopathy. Journal of Neurochemistry. 106: 96-106. PMID 18346207 DOI: 10.1111/J.1471-4159.2008.05339.X |
0.653 |
|
2008 |
Spires-Jones TL, de Calignon A, Matsui T, Zehr C, Pitstick R, Wu HY, Osetek JD, Jones PB, Bacskai BJ, Feany MB, Carlson GA, Ashe KH, Lewis J, Hyman BT. In vivo imaging reveals dissociation between caspase activation and acute neuronal death in tangle-bearing neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 862-7. PMID 18216194 DOI: 10.1523/Jneurosci.3072-08.2008 |
0.32 |
|
2007 |
Bolmont T, Clavaguera F, Meyer-Luehmann M, Herzig MC, Radde R, Staufenbiel M, Lewis J, Hutton M, Tolnay M, Jucker M. Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice. The American Journal of Pathology. 171: 2012-20. PMID 18055549 DOI: 10.2353/Ajpath.2007.070403 |
0.589 |
|
2007 |
Berger Z, Roder H, Hanna A, Carlson A, Rangachari V, Yue M, Wszolek Z, Ashe K, Knight J, Dickson D, Andorfer C, Rosenberry TL, Lewis J, Hutton M, Janus C. Accumulation of pathological tau species and memory loss in a conditional model of tauopathy. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 3650-62. PMID 17409229 DOI: 10.1523/Jneurosci.0587-07.2007 |
0.799 |
|
2007 |
Lin W, Zehr C, Lewis J, Dickson DW. Progranulin is located in secretory granules and vesicles of neutrophils and macrophages by immunogold electron microscopy Journal of Neuropathology and Experimental Neurology. 66: 422. DOI: 10.1097/01.Jnen.0000268990.82771.11 |
0.343 |
|
2007 |
Lin W, Zehr C, Lewis J, Dickson DW. Progranulin is located in secretory granules and vesicles of neutrophils and macrophages by immunogold electron microscopy The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A22-B |
0.343 |
|
2006 |
Katsuse O, Lin WL, Lewis J, Hutton ML, Dickson DW. Neurofibrillary tangle-related synaptic alterations of spinal motor neurons of P301L tau transgenic mice. Neuroscience Letters. 409: 95-9. PMID 17010516 DOI: 10.1016/J.Neulet.2006.09.021 |
0.622 |
|
2006 |
Le Corre S, Klafki HW, Plesnila N, Hübinger G, Obermeier A, Sahagún H, Monse B, Seneci P, Lewis J, Eriksen J, Zehr C, Yue M, McGowan E, Dickson DW, Hutton M, et al. An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice. Proceedings of the National Academy of Sciences of the United States of America. 103: 9673-8. PMID 16769887 DOI: 10.1073/Pnas.0602913103 |
0.656 |
|
2006 |
Lewis J, Zehr C, Knight J, Dickson DW, Hutton M, McGowan E. P1-117: Kinetics of tau suppression in the rTg4510 inducible model of tauopathy Alzheimer's & Dementia. 2: S129-S130. DOI: 10.1016/J.Jalz.2006.05.493 |
0.607 |
|
2006 |
Zehr C, Lin W, Knight J, Dickson DW, Hutton M, Lewis J. P1-102: Apoptosis of oligodendrocytes in an inducible model of tauopathy Alzheimer's & Dementia. 2: S125-S125. DOI: 10.1016/J.Jalz.2006.05.478 |
0.551 |
|
2006 |
Berger Z, Lewis J, Andorfer C, Yue M, Rosenberry T, Hutton M. P1-087: Identification of toxic tau species Alzheimer's & Dementia. 2: S120-S120. DOI: 10.1016/J.Jalz.2006.05.462 |
0.742 |
|
2006 |
Andorfer CA, Yue M, Janus C, Lewis J, Hutton M. P1-002: Synaptic degeneration and memory loss in a model of tauopathy Alzheimer's & Dementia. 2: S94-S95. DOI: 10.1016/J.Jalz.2006.05.377 |
0.473 |
|
2006 |
Lewis J, Zehr C, Andorfer C, Eriksen J, Knight J, Yue M, Robinson T, Berger Z, Hanna A, Dickson DW, Janus C, McGowan E, Hutton M. O4-05-01: Methods of cell death and recovery in the rTg4510 and iP301L inducible mouse models of tauopathy Alzheimer's & Dementia. 2: S84-S84. DOI: 10.1016/J.Jalz.2006.05.327 |
0.747 |
|
2006 |
Eriksen J, Zehr C, Berger Z, Robinson T, Lewis J, Hutton M. P3-293: Tau clearance through protein degradation pathways Alzheimer's & Dementia. 2: S461-S462. DOI: 10.1016/J.Jalz.2006.05.1562 |
0.748 |
|
2006 |
Hutton M, Melquist S, Baker M, Zehr C, McGowan E, Dickson D, Eriksen J, Ashe K, Stephan D, Lewis J. S2-02-06: The tauopathies: From genetics to animal models Alzheimer's & Dementia. 2: S26-S26. DOI: 10.1016/J.Jalz.2006.05.086 |
0.751 |
|
2005 |
Lin WL, Zehr C, Lewis J, Hutton M, Yen SH, Dickson DW. Progressive white matter pathology in the spinal cord of transgenic mice expressing mutant (P301L) human tau. Journal of Neurocytology. 34: 397-410. PMID 16902761 DOI: 10.1007/S11068-006-8726-0 |
0.609 |
|
2005 |
Ramsden M, Kotilinek L, Forster C, Paulson J, McGowan E, SantaCruz K, Guimaraes A, Yue M, Lewis J, Carlson G, Hutton M, Ashe KH. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 10637-47. PMID 16291936 DOI: 10.1523/Jneurosci.3279-05.2005 |
0.62 |
|
2005 |
Santacruz K, Lewis J, Spires T, Paulson J, Kotilinek L, Ingelsson M, Guimaraes A, DeTure M, Ramsden M, McGowan E, Forster C, Yue M, Orne J, Janus C, Mariash A, et al. Tau suppression in a neurodegenerative mouse model improves memory function. Science (New York, N.Y.). 309: 476-81. PMID 16020737 DOI: 10.1126/Science.1113694 |
0.576 |
|
2005 |
Noble W, Planel E, Zehr C, Olm V, Meyerson J, Suleman F, Gaynor K, Wang L, LaFrancois J, Feinstein B, Burns M, Krishnamurthy P, Wen Y, Bhat R, Lewis J, et al. Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proceedings of the National Academy of Sciences of the United States of America. 102: 6990-5. PMID 15867159 DOI: 10.1073/Pnas.0500466102 |
0.518 |
|
2005 |
Halverson RA, Lewis J, Frausto S, Hutton M, Muma NA. Tau protein is cross-linked by transglutaminase in P301L tau transgenic mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 1226-33. PMID 15689560 DOI: 10.1523/Jneurosci.3263-04.2005 |
0.625 |
|
2004 |
Sahara N, Vega IE, Ishizawa T, Lewis J, McGowan E, Hutton M, Dickson D, Yen SH. Phosphorylated p38MAPK specific antibodies cross-react with sarkosyl-insoluble hyperphosphorylated tau proteins. Journal of Neurochemistry. 90: 829-38. PMID 15287888 DOI: 10.1111/J.1471-4159.2004.02558.X |
0.673 |
|
2004 |
Arendash GW, Lewis J, Leighty RE, McGowan E, Cracchiolo JR, Hutton M, Garcia MF. Multi-metric behavioral comparison of APPsw and P301L models for Alzheimer's disease: linkage of poorer cognitive performance to tau pathology in forebrain. Brain Research. 1012: 29-41. PMID 15158158 DOI: 10.1016/J.Brainres.2004.02.081 |
0.597 |
|
2004 |
Garcia MF, Gordon MN, Hutton M, Lewis J, McGowan E, Dickey CA, Morgan D, Arendash GW. The retinal degeneration (rd) gene seriously impairs spatial cognitive performance in normal and Alzheimer's transgenic mice. Neuroreport. 15: 73-7. PMID 15106834 DOI: 10.1097/00001756-200401190-00015 |
0.657 |
|
2004 |
Zehr C, Lewis J, McGowan E, Crook J, Lin WL, Godwin K, Knight J, Dickson DW, Hutton M. Apoptosis in oligodendrocytes is associated with axonal degeneration in P301L tau mice. Neurobiology of Disease. 15: 553-62. PMID 15056463 DOI: 10.1016/J.Nbd.2003.12.011 |
0.644 |
|
2004 |
Petrucelli L, Dickson D, Kehoe K, Taylor J, Snyder H, Grover A, De Lucia M, McGowan E, Lewis J, Prihar G, Kim J, Dillmann WH, Browne SE, Hall A, Voellmy R, et al. CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Human Molecular Genetics. 13: 703-14. PMID 14962978 DOI: 10.1093/Hmg/Ddh083 |
0.683 |
|
2004 |
Klein RL, Lin WL, Dickson DW, Lewis J, Hutton M, Duff K, Meyer EM, King MA. Rapid neurofibrillary tangle formation after localized gene transfer of mutated tau. The American Journal of Pathology. 164: 347-53. PMID 14695347 DOI: 10.1016/S0002-9440(10)63124-0 |
0.647 |
|
2004 |
Hutton M, Melrose H, Zehr C, McGowan E, Dickson DW, Yen S, Kehoe K, Taylor J, Eriksen J, Petrucelli L, Lewis J. P4-422 Mechanism of neurofibrillary degeneration in a mouse model of tauopathy and progress towards identification of a therapeutic target Neurobiology of Aging. 25: S594. DOI: 10.1016/S0197-4580(04)81978-X |
0.603 |
|
2004 |
Horsburgh KJ, Pickford F, Kennedy L, Lewis J, Hutton M, McGowan E. P3-253 Temporal alterations in tau and apolipoprotein E after hippocampal denervation in mutant tau mice: a preliminary investigation Neurobiology of Aging. 25: S426-S427. DOI: 10.1016/S0197-4580(04)81403-9 |
0.596 |
|
2004 |
Petrucelli L, Taylor J, Kehoe K, Lewis J, McGowan E, Snyder H, Wolozin B, Dawson TM, Dillmann W, Voellmy R, Hutton M. P3-228 Chip and HSP70 regulate tau ubiquitination, degradation and aggregation Neurobiology of Aging. 25: S419-S420. DOI: 10.1016/S0197-4580(04)81378-2 |
0.529 |
|
2004 |
Bailey C, Pickord F, Lewis J, Heckman M, Yue M, O'Donnell K, Yu C, Hutton M, McGowan E. P2-095 The effect of ovariectomy on pathology and phenotype in Tau (P301L) transgenic mice Neurobiology of Aging. 25: S251. DOI: 10.1016/S0197-4580(04)80842-X |
0.623 |
|
2004 |
Zehr C, Godwin K, Lin W, Dickson DW, McGowan E, Lewis J, Hutton M. P2-070 Axonal degeneration in P301L Tau transgenic mice Neurobiology of Aging. 25: S243-S244. DOI: 10.1016/S0197-4580(04)80817-0 |
0.634 |
|
2003 |
Lin WL, Lewis J, Yen SH, Hutton M, Dickson DW. Ultrastructural neuronal pathology in transgenic mice expressing mutant (P301L) human tau. Journal of Neurocytology. 32: 1091-105. PMID 15044841 DOI: 10.1023/B:Neur.0000021904.61387.95 |
0.661 |
|
2003 |
Ishizawa T, Sahara N, Ishiguro K, Kersh J, McGowan E, Lewis J, Hutton M, Dickson DW, Yen SH. Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice. The American Journal of Pathology. 163: 1057-67. PMID 12937146 DOI: 10.1016/S0002-9440(10)63465-7 |
0.689 |
|
2003 |
Lin WL, Lewis J, Yen SH, Hutton M, Dickson DW. Filamentous tau in oligodendrocytes and astrocytes of transgenic mice expressing the human tau isoform with the P301L mutation. The American Journal of Pathology. 162: 213-8. PMID 12507904 DOI: 10.1016/S0002-9440(10)63812-6 |
0.693 |
|
2002 |
Sahara N, Lewis J, DeTure M, McGowan E, Dickson DW, Hutton M, Yen SH. Assembly of tau in transgenic animals expressing P301L tau: alteration of phosphorylation and solubility. Journal of Neurochemistry. 83: 1498-508. PMID 12472903 DOI: 10.1046/J.1471-4159.2002.01241.X |
0.666 |
|
2001 |
Hutton M, Lewis J, Dickson D, Yen SH, McGowan E. Analysis of tauopathies with transgenic mice. Trends in Molecular Medicine. 7: 467-70. PMID 11597522 DOI: 10.1016/S1471-4914(01)02123-2 |
0.682 |
|
2001 |
Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, Yen SH, Sahara N, Skipper L, Yager D, Eckman C, Hardy J, Hutton M, McGowan E. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science (New York, N.Y.). 293: 1487-91. PMID 11520987 DOI: 10.1126/Science.1058189 |
0.703 |
|
2001 |
Wittmann CW, Wszolek MF, Shulman JM, Salvaterra PM, Lewis J, Hutton M, Feany MB. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science (New York, N.Y.). 293: 711-4. PMID 11408621 DOI: 10.1126/Science.1062382 |
0.61 |
|
2000 |
van Slegtenhorst M, Lewis J, Hutton M. The molecular genetics of the tauopathies. Experimental Gerontology. 35: 461-71. PMID 10959034 DOI: 10.1016/S0531-5565(00)00114-5 |
0.58 |
|
2000 |
Lewis J, McGowan E, Rockwood J, Melrose H, Nacharaju P, Van Slegtenhorst M, Gwinn-Hardy K, Paul Murphy M, Baker M, Yu X, Duff K, Hardy J, Corral A, Lin WL, Yen SH, et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nature Genetics. 25: 402-5. PMID 10932182 DOI: 10.1038/78078 |
0.72 |
|
2000 |
DeTure M, Ko LW, Yen S, Nacharaju P, Easson C, Lewis J, van Slegtenhorst M, Hutton M, Yen SH. Missense tau mutations identified in FTDP-17 have a small effect on tau-microtubule interactions. Brain Research. 853: 5-14. PMID 10627302 DOI: 10.1016/S0006-8993(99)02124-1 |
0.577 |
|
2000 |
Lewis J, Davies P, Yen S, Dickson DW, Hutton M. Neurofibrillary tangles, neuronal loss, and severe motor changes develop in transgenic mice expressing tau (4R0N) with the frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17) mutation P301L Neurobiology of Aging. 21: 59. DOI: 10.1016/S0197-4580(00)82491-4 |
0.659 |
|
2000 |
Lewis J, Hutton M. Animal models of tau dysfunction Neuroscience News. 3: 63-72. |
0.324 |
|
1999 |
Grover A, Houlden H, Baker M, Adamson J, Lewis J, Prihar G, Pickering-Brown S, Duff K, Hutton M. 5' splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10. The Journal of Biological Chemistry. 274: 15134-43. PMID 10329720 DOI: 10.1074/Jbc.274.21.15134 |
0.531 |
|
1999 |
Nacharaju P, Lewis J, Easson C, Yen S, Hackett J, Hutton M, Yen SH. Accelerated filament formation from tau protein with specific FTDP-17 missense mutations. Febs Letters. 447: 195-9. PMID 10214944 DOI: 10.1097/00005072-199905000-00157 |
0.569 |
|
1998 |
Whitney JB, Leder A, Lewis J, Popp RA, Paszty C, Rubin EM, Shehee WR, Townes TM, Smithies O. Rapid genotyping of mice with hemoglobinopathies and globin transgenes. Biochemical Genetics. 36: 65-77. PMID 9562907 DOI: 10.1023/A:1018752219810 |
0.585 |
|
1998 |
Lewis J, Yang B, Kim R, Sierakowska H, Kole R, Smithies O, Maeda N. A common human beta globin splicing mutation modeled in mice. Blood. 91: 2152-6. PMID 9490703 DOI: 10.1182/Blood.V91.6.2152.2152_2152_2156 |
0.722 |
|
1998 |
Lewis J, Yang B, Kim R, Sierakowska H, Kole R, Smithies O, Maeda N. A Common Human β Globin Splicing Mutation Modeled in Mice Blood. 91: 2152-2156. DOI: 10.1182/blood.V91.6.2152.2152_2152_2156 |
0.444 |
|
1996 |
Lewis J, Yang B, Detloff P, Smithies O. Gene modification via "plug and socket" gene targeting. The Journal of Clinical Investigation. 97: 3-5. PMID 8550847 DOI: 10.1172/Jci118403 |
0.701 |
|
1995 |
Yang B, Kirby S, Lewis J, Detloff PJ, Maeda N, Smithies O. A mouse model for beta 0-thalassemia. Proceedings of the National Academy of Sciences of the United States of America. 92: 11608-12. PMID 8524813 DOI: 10.1073/Pnas.92.25.11608 |
0.777 |
|
1994 |
Detloff PJ, Lewis J, John SW, Shehee WR, Langenbach R, Maeda N, Smithies O. Deletion and replacement of the mouse adult beta-globin genes by a "plug and socket" repeated targeting strategy. Molecular and Cellular Biology. 14: 6936-43. PMID 7935410 DOI: 10.1128/Mcb.14.10.6936 |
0.763 |
|
1993 |
Bird SR, Bailey R, Lewis J. Heart rates during competitive orienteering. British Journal of Sports Medicine. 27: 53-7. PMID 8457815 |
0.413 |
|
Show low-probability matches. |